BlackRock Institutional Trust’s Amphastar Pharmaceuticals AMPH Stock Holding History

BlackRock Institutional Trust’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$16.7M	Buy	908,921 +56,815	+7%	+$1.11M	﹤0.01%	2094
2016 Q3	$16.2M	Buy	852,106 +27,993	+3%	+$508K	﹤0.01%	2034
2016 Q2	$13.3M	Buy	824,113 +256,940	+45%	+$3.63M	﹤0.01%	2109
2016 Q1	$6.81M	Sell	567,173 -648	-0.1%	-$7.64K	﹤0.01%	2507
2015 Q4	$8.08M	Buy	567,821 +122,851	+28%	+$1.62M	﹤0.01%	2466
2015 Q3	$5.2M	Buy	444,970 +177,465	+66%	+$2.66M	﹤0.01%	2696
2015 Q2	$4.7M	Buy	267,505 +194,589	+267%	+$3.03M	﹤0.01%	2792
2015 Q1	$1.09M	Sell	72,916 -946	-1%	-$12.6K	﹤0.01%	3320
2014 Q4	$858K	Sell	73,862 -17,963	-20%	-$196K	﹤0.01%	3387
2014 Q3	$1.07M	Buy	+91,825	New	+$957K	﹤0.01%	3299

Other funds holding AMPH

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock Institutional Trust's AMPH Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Amphastar Pharmaceuticals (AMPH) stake by 6.7% in Q4 2016, buying an estimated $1.11M and bringing the position to 908,921 shares worth $16.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

BlackRock Institutional Trust first reported a position in AMPH in Q3 2014 and has held it in 10 quarters since. 138 funds tracked by Wall St. Rank hold AMPH as of Q4 2016.

BlackRock Institutional Trust held 908,921 shares of Amphastar Pharmaceuticals worth $16.7M as of Q4 2016.
BlackRock Institutional Trust bought 56,815 Amphastar Pharmaceuticals shares in Q4 2016, an estimated $1.11M.
Amphastar Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2094 holding.
BlackRock Institutional Trust first reported a position in Amphastar Pharmaceuticals in Q3 2014 and has held it in 10 quarters since.
138 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.